Detalhe da pesquisa
1.
MAIT Cells in Viral Hepatitis and Liver Diseases.
Crit Rev Immunol
; 41(5): 37-47, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381138
2.
TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.
Gut
; 2020 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097558
3.
Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro.
J Virol
; 89(14): 7433-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972537
4.
Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma.
Eur J Gastroenterol Hepatol
; 33(1S Suppl 1): e247-e253, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33323760
5.
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells.
Nat Med
; 27(1): 78-85, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184509
6.
CD4+ T cell responses in human viral infection: lessons from hepatitis C.
J Clin Invest
; 130(2): 595-597, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31904589
7.
Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells.
Front Immunol
; 9: 756, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29740432